Handelsinvest Investeringsforvaltning’s Acadia Pharmaceuticals ACAD Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-58,600	Closed	-$1.32M	–	107
2018 Q1	$1.32M	Hold	58,600	–	–	0.29%	56
2017 Q4	$1.76M	Hold	58,600	–	–	0.39%	53
2017 Q3	$2.21M	Hold	58,600	–	–	0.52%	44
2017 Q2	$1.63M	Buy	58,600 +36,700	+168%	+$1.09M	0.41%	52
2017 Q1	$753K	Buy	21,900 +7,500	+52%	+$265K	0.21%	83
2016 Q4	$415K	Hold	14,400	–	–	0.15%	84
2016 Q3	$458K	Hold	14,400	–	–	0.17%	87
2016 Q2	$467K	Hold	14,400	–	–	0.18%	86
2016 Q1	$403K	Hold	14,400	–	–	0.14%	105
2015 Q4	$513K	Buy	+14,400	New	+$507K	0.18%	100

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's ACAD Position: Q2 2018 in Review

Handelsinvest Investeringsforvaltning sold out of Acadia Pharmaceuticals (ACAD) in Q2 2018, closing a stake of 58,600 shares — an estimated $1.32M sold.

Handelsinvest Investeringsforvaltning first reported a position in ACAD in Q4 2015 and held it in 10 quarters. The position peaked at $2.21M in Q3 2017. 187 funds tracked by Wall St. Rank hold ACAD as of Q2 2018.

Handelsinvest Investeringsforvaltning reported no remaining Acadia Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 58,600 Acadia Pharmaceuticals shares in Q2 2018, an estimated $1.32M.
Handelsinvest Investeringsforvaltning first reported a position in Acadia Pharmaceuticals in Q4 2015 and held it in 10 quarters.
Handelsinvest Investeringsforvaltning's Acadia Pharmaceuticals position peaked at $2.21M in Q3 2017.
187 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2018.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q2 2018, filed 9 Aug 2018.